Skip to main content
. 2017 May 24;11(5):e0005602. doi: 10.1371/journal.pntd.0005602

Fig 5. Cost-effectiveness acceptability curves.

Fig 5

Results show the screening strategy versus: A) the chloroquine strategy in males, B) the primaquine strategy for males, C) the chloroquine strategy in females and D) the primaquine strategy in females.